T-group (topology)
1.1.8 Aminomethyltransferase beta-barrel domain
Ligands and drugs
3,543
Member domains
146
with ligand contacts (≤ 4 Å)
4.1% of members
119
with DrugDomain annotations
3.4% of members
75
with a DrugBank compound
2.1% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 1.1.8 belongs to X-group 1 cradle loop barrel, which binds 9.4 ligand superclasses per 20 proteins, broader than 87% of the 256 X-groups with enough proteins to compare. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB02031 | THG | (6S)-5,6,7,8-tetrahydrofolic acid | 5 |
| DB03946 | DHB | 3,4-Dihydroxybenzoic Acid | 5 |
| DB00120 | PHE | Phenylalanine | 4 |
| DB04315 | GDP | Guanosine-5'-Diphosphate | 4 |
| DB01972 | 5GP | Guanosine-5'-Monophosphate | 3 |
| DB02130 | VNL | Vanillic acid | 3 |
| DB03619 | DXC | Deoxycholic acid | 3 |
| DB04124 | MAU | Aurodox | 3 |
| DB04977 | ZIY | Plitidepsin | 3 |
| DB11256 | THH | Levomefolic acid | 3 |
| DB01593 | — | — | 2 |
| DB14487 | — | — | 2 |
| DB14533 | — | — | 2 |
| DB00116 | — | — | 1 |
| DB00157 | — | NADH | 1 |
| DB00158 | FOL | Folic acid | 1 |
| DB03256 | FON | (6R)-Folinic acid | 1 |
| DB04789 | — | — | 1 |
| DB09130 | — | — | 1 |
| DB11596 | FFO | Levoleucovorin | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| KIR | KIRROMYCIN | 14 |
| ENX | ENACYLOXIN IIA | 5 |
| NAmetal | SODIUM ION | 5 |
| CL | CHLORIDE ION | 4 |
| DHB | 3,4-DIHYDROXYBENZOIC ACID | 4 |
| 5GP | GUANOSINE-5'-MONOPHOSPHATE | 3 |
| DXC | (3ALPHA,5BETA,12ALPHA)-3,12-DIHYDROXYCHOLAN-24-OIC ACID | 3 |
| GDP | GUANOSINE-5'-DIPHOSPHATE | 3 |
| MAU | N-METHYL KIRROMYCIN | 3 |
| MGmetal | MAGNESIUM ION | 3 |
| VNL | 4-HYDROXY-3-METHOXYBENZOATE | 3 |
| 7WR | 3-methoxy-4,5-bis(oxidanyl)benzoic acid | 2 |
| 85C | 1-(3-chloro-4-methylphenyl)-3-({2-[(3S)-2,6-dioxopiperidin-3-yl]-1-oxo-2,3-dihydro-1H-isoindol-5-yl}methyl)urea | 2 |
| A1C4S | N-{6-[(3R)-2,6-dioxopiperidin-3-yl]naphthalen-1-yl}-N'-{2-[6-(trifluoromethyl)-1-benzothiophen-2-yl]propan-2-yl}urea | 2 |
| A1IWG | 2-[(3~{S})-2,6-bis(oxidanylidene)piperidin-3-yl]-6-fluoranyl-1-oxidanylidene-3~{H}-isoindole-5-carboxylic acid | 2 |
| BME | BETA-MERCAPTOETHANOL | 2 |
| GPE | L-ALPHA-GLYCEROPHOSPHORYLETHANOLAMINE | 2 |
| IOD | IODIDE ION | 2 |
| PUL | (1S,2S,3E,5E,7E,10S,11S,12S)-12-[(2R,4E,6E,8Z,10R,12E,14E,16Z,18S,19Z)-10,18-DIHYDROXY-12,16,19-TRIMETHYL-11,22-DIOXOOXACYCLODOCOSA-4,6,8,12,14,16,19-HEPTAEN-2-YL]-2,11-DIHYDROXY-1,10-DIMETHYL-9-OXOTRIDECA-3,5,7-TRIEN-1-YL 6-DEOXY-2,4-DI-O-METHYL-BETA-L-GALACTOPYRANOSIDE | 2 |
| SCN | THIOCYANATE ION | 2 |